The search result changed since you submitted your search request. Documents might be displayed in a different sort order.
  • search hit 1 of 16
Back to Result List

The P429L loss of function mutation of the human glycine transporter 2 associated with hyperekplexia

Please always quote using this URN: urn:nbn:de:bvb:20-opus-206158
  • Glycine transporter 2 (GlyT2) mutations across the entire sequence have been shown to represent the presynaptic component of the neurological disease hyperekplexia. Dominant, recessive and compound heterozygous mutations have been identified, most of them leading to impaired glycine uptake. Here, we identified a novel loss of function mutation of the GlyT2 resulting from an amino acid exchange of proline 429 to leucine in a family with both parents being heterozygous carriers. A homozygous child suffered from severe neuromotor deficits. WeGlycine transporter 2 (GlyT2) mutations across the entire sequence have been shown to represent the presynaptic component of the neurological disease hyperekplexia. Dominant, recessive and compound heterozygous mutations have been identified, most of them leading to impaired glycine uptake. Here, we identified a novel loss of function mutation of the GlyT2 resulting from an amino acid exchange of proline 429 to leucine in a family with both parents being heterozygous carriers. A homozygous child suffered from severe neuromotor deficits. We characterised the GlyT2P429L variant at the molecular, cellular and protein level. Functionality was determined by glycine uptake assays. Homology modelling revealed that the mutation localises to α‐helix 5, presumably disrupting the integrity of this α‐helix. GlyT2P429L shows protein trafficking through various intracellular compartments to the cellular surface. However, the protein expression at the whole cell level was significantly reduced. Although present at the cellular surface, GlyT2P429L demonstrated a loss of protein function. Coexpression of the mutant with the wild‐type protein, reflecting the situation in the parents, did not affect transporter function, thus explaining their non‐symptomatic phenotype. Nevertheless, when the mutant was expressed in excess compared with the wild‐type protein, glycine uptake was significantly reduced. Thus, these data demonstrate that the proline residue at position 429 is structurally important for the correct formation of α‐helix 5. The failure in functionality of the mutated GlyT2 is most probably due to structural changes localised in close proximity to the sodium‐binding site of the transporter.show moreshow less

Download full text files

Export metadata

Additional Services

Share in Twitter Search Google Scholar Statistics
Metadaten
Author: Alexandra Kitzenmaier, Natascha Schaefer, Vikram Babu Kasaragod, Tilman Polster, Ralph Hantschmann, Hermann Schindelin, Carmen Villmann
URN:urn:nbn:de:bvb:20-opus-206158
Document Type:Journal article
Faculties:Medizinische Fakultät / Institut für Klinische Neurobiologie
Fakultät für Biologie / Rudolf-Virchow-Zentrum
Language:English
Parent Title (English):European Journal of Neuroscience
Year of Completion:2019
Volume:50
Issue:12
Pagenumber:3906-3920
Source:European Journal of Neuroscience (2019) 50:12, 3906-3920. https://doi.org/10.1111/ejn.14533
DOI:https://doi.org/10.1111/ejn.14533
Dewey Decimal Classification:6 Technik, Medizin, angewandte Wissenschaften / 61 Medizin und Gesundheit / 610 Medizin und Gesundheit
Tag:glycine transporter 2; glyvine uptake; loss of function; presynaptic hyperekplexia; protein transport; structural disruption
Release Date:2020/06/29
Licence (German):License LogoCC BY: Creative-Commons-Lizenz: Namensnennung 4.0 International